Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-06-15

Clinical Trial Update: Electromagnetic Stimulation (FREMS) in Patients With Painful Diabetic Neuropathy [Phase 2, Phase 3]

View source ↗

Summary

The update notes that electromagnetic stimulation using FREMS has completed Phase 2 and Phase 3 trials in patients with Painful Diabetic Neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FREMS (Frequency Rhythmic Electrical Modulation System) electromagnetic stimulation

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Painful Diabetic Neuropathy | Phase 2, Phase 3 | Status: COMPLETED